Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$20,083 Mln
P/E Ratio
22.91
P/B Ratio
1.61
Industry P/E
--
Debt to Equity
0.5
ROE
0.07 %
ROCE
4.87 %
Div. Yield
0.95 %
Book Value
61.42
EPS
4.45
CFO
$14,033.30 Mln
EBITDA
$21,015.70 Mln
Net Profit
$5,184.30 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Zimmer Biomet Holdings (ZBH)
| -3.66 | -9.26 | -9.61 | -14.74 | -6.09 | -2.24 | -1.05 |
|
BSE Sensex*
| 2.70 | 3.81 | 5.88 | 8.99 | 11.79 | 20.14 | 11.36 |
|
S&P Midcap 400
| -8.80 | -4.26 | -12.25 | -1.81 | 4.06 | 11.99 | 6.45 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Zimmer Biomet Holdings (ZBH)
| -13.10 | -4.55 | 3.45 | -17.02 | 3.77 | 45.37 | -13.24 |
|
S&P Midcap 400
| 12.12 | 14.45 | -14.48 | 23.21 | 11.81 | 24.05 | -12.43 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 204.63 | 58,885.65 | 34.47 | 6.76 | |
| 75.54 | 44,540.81 | 31.95 | 50.15 | |
| 433.99 | 35,736.57 | 41 | 57.66 | |
| 225.77 | 37,047.61 | 52.67 | 13.63 |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products,... including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Address: 345 East Main Street, Warsaw, IN, United States, 46580 Read more
COO, President, CEO & Director
Mr. Ivan Tornos
COO, President, CEO & Director
Mr. Ivan Tornos
Headquarters
Warsaw, IN
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Zimmer Biomet Holdings Inc (ZBH) stood at $ 21,365 Mln as on 31-Dec-24
The share price of Zimmer Biomet Holdings Inc (ZBH) is $101.76 (NYSE) as of 28-Apr-2025 16:10 EDT. Zimmer Biomet Holdings Inc (ZBH) has given a return of -6.09% in the last 3 years.
Zimmer Biomet Holdings Inc (ZBH) has a market capitalisation of $ 20,083 Mln as on 28-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/E ratio of Zimmer Biomet Holdings Inc (ZBH) is 22.91 times as on 28-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Zimmer Biomet Holdings Inc (ZBH) and enter the required number of quantities and click on buy to purchase the shares of Zimmer Biomet Holdings Inc (ZBH).
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Address: 345 East Main Street, Warsaw, IN, United States, 46580
The CEO & director of Mr. Ivan Tornos. is Zimmer Biomet Holdings Inc (ZBH), and CFO & Sr. VP is Mr. Ivan Tornos.
There is no promoter pledging in Zimmer Biomet Holdings Inc (ZBH).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
5,809
|
|
|
4,135
|
|
|
3,588
|
|
|
3,457
|
| Zimmer Biomet Holdings Inc. (ZBH) | Ratios |
|---|---|
|
Return on equity(%)
|
7.25
|
|
Operating margin(%)
|
16.74
|
|
Net Margin(%)
|
11.77
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Zimmer Biomet Holdings Inc (ZBH) was $904 Mln.
$0.25
(
